Bind Therapeutics completes follow-on

Bind Therapeutics Inc. (NASDAQ:BIND), Cambridge, Mass. Business: Cancer, Drug delivery Date completed: 2015-02-05 Type: Follow-on Raised: $21.5 million Units: 3.7 million Price: $5.75 (unit) Shares af...